I'm breaking my promise to not veer off the Resverlogix track for just a quick news update that Kausik Ray announced some pretty awesome LDL-C lowering results today at EAS 2018 for the RNAi based, PCSK9 drug Inclisiran, from The Medicines Company and Alnylam Pharmaceuticals. If this price is right this could dominate the market for new LDL-C lowering drugs. Amazing duration with efficacy beyond 6 months after single injection. Almost like a vaccine! Phase 3 still ongoing, so won't be coming to market anytime soon.

https://www.businesswire.com/news/home/20180507005683/en/Medicines-Company-Announces-Inclisiran-Data-Showing-Significant